Disease Flare after Tyrosine Kinase Inhibitor...

Clinical Cancer Research 2011 Vol. 17; Iss. 19

Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

Chaft, J. E., Oxnard, G. R., Sima, C. S., Kris, M. G., Miller, V. A., Riely, G. J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Year:
2011
Language:
english
Pages:
6
DOI:
10.1158/1078-0432.ccr-11-1468
File:
PDF, 338 KB
english, 2011
Conversion to is in progress
Conversion to is failed